Guk-Hyun Hwang
Director Ejecutivo en BELLEVUE LIFE SCIENCES ACQUISITION CORP. .
Fortuna: 14 M $ al 30/04/2024
Perfil
Mr. Guk-Hyun Hwang is a Co-Chairman at Vaximm AG, a Chief Executive Officer & Director at BCM Europe AG, a Chief Executive Officer & Director at Bellevue Life Sciences Acquisition Corp., a Chairman & Chief Executive Officer at OSR Holdings Co., Ltd.
and a Managing Partner at Bellevue Capital Management LLC.
He is on the Board of Directors at BCM Europe AG and Bellevue Life Sciences Acquisition Corp.
He received his undergraduate degree from Korea University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 18/04/2024 | 1 320 500 ( 23.48% ) | 14 M $ | 30/04/2024 |
Cargos activos de Guk-Hyun Hwang
| Empresas | Cargo | Inicio |
|---|---|---|
| BELLEVUE LIFE SCIENCES ACQUISITION CORP. | Director Ejecutivo | 01/03/2020 |
| Bellevue Capital Management LLC | Fundador | 01/08/2012 |
OSR Holdings Co., Ltd.
 OSR Holdings Co., Ltd. Pharmaceuticals: MajorHealth Technology OSR Holdings Co., Ltd. is a South Korean healthcare company that develops and licenses innovative biomedical therapies based on proprietary platform technologies to address unmet medical needs. The private company is based in an undisclosed location. The company wholly-owns three operating subsidiaries focused on developing therapeutic drugs in the areas of oncology and osteoarthritis, and the third is a distributor of medical devices for the treatment of neurovascular and other diseases. OSR Holdings signed a letter of intent to acquire Landmark Bioventures AG, a Swiss company that operates through four different biotech ventures with therapeutic focuses on oncology and immunology. The company was founded in 2019, and the CEO is Sean Chung. | Director Ejecutivo | 01/07/2019 |
BCM Europe AG
 BCM Europe AG Investment ManagersFinance BCM Europe AG provides investment and financial advisory services. The private company is based in Zug, Switzerland and has subsidiaries in Switzerland. Guk-Hyun Hwang has been the CEO of the Swiss company since 2020. | Director Ejecutivo | 01/03/2020 |
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Presidente | 01/11/2022 |
Formación de Guk-Hyun Hwang.
| Korea University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BELLEVUE LIFE SCIENCES ACQUISITION CORP. | Finance |
| Empresas privadas | 4 |
|---|---|
OSR Holdings Co., Ltd.
OSR Holdings Co., Ltd. Pharmaceuticals: MajorHealth Technology OSR Holdings Co., Ltd. is a South Korean healthcare company that develops and licenses innovative biomedical therapies based on proprietary platform technologies to address unmet medical needs. The private company is based in an undisclosed location. The company wholly-owns three operating subsidiaries focused on developing therapeutic drugs in the areas of oncology and osteoarthritis, and the third is a distributor of medical devices for the treatment of neurovascular and other diseases. OSR Holdings signed a letter of intent to acquire Landmark Bioventures AG, a Swiss company that operates through four different biotech ventures with therapeutic focuses on oncology and immunology. The company was founded in 2019, and the CEO is Sean Chung. | Health Technology |
BCM Europe AG
BCM Europe AG Investment ManagersFinance BCM Europe AG provides investment and financial advisory services. The private company is based in Zug, Switzerland and has subsidiaries in Switzerland. Guk-Hyun Hwang has been the CEO of the Swiss company since 2020. | Finance |
| Bellevue Capital Management LLC | |
Vaximm AG
Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Commercial Services |
- Bolsa de valores
- Insiders
- Guk-Hyun Hwang
